These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 17937948)

  • 1. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M; Parker M; Guhring P; Mulhall JP
    J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
    Shemtov OM; Radomski SB; Crook J
    Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer.
    Harrington C; Campbell G; Wynne C; Atkinson C
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):224-8. PubMed ID: 20598010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
    Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.
    Valero J; Cambeiro M; Galán C; Teijeira M; Romero P; Zudaire J; Moreno M; Ciérvide R; Aristu JJ; Martínez-Monge R
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):386-92. PubMed ID: 19427741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
    Schiff JD; Bar-Chama N; Cesaretti J; Stock R
    BJU Int; 2006 Dec; 98(6):1255-8. PubMed ID: 17125483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
    Galalae RM; Martinez A; Mate T; Mitchell C; Edmundson G; Nuernberg N; Eulau S; Gustafson G; Gribble M; Kovács G
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1048-55. PubMed ID: 15001244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men agedGómez-Iturriaga Piña A; Crook J; Borg J; Lockwood G; Fleshner N
    Urology; 2010 Jun; 75(6):1412-6. PubMed ID: 20035986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Favorable effect of sildenafil on erectile dysfunction in patients after radiotherapy for prostate cancer; randomised, double-blind, placebo-controlled crossover study].
    Incrocci L; Hop WC; Slob AK
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1687-90. PubMed ID: 14569951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
    Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?
    Feigenberg SJ; Hanlon AL; Horwitz EM; Uzzo RG; Eisenberg DF; Pollack A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1003-10. PubMed ID: 15752879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to sildenafil citrate following radiation therapy for prostate cancer.
    Teloken PE; Parker M; Mohideen N; Mulhall JP
    J Sex Med; 2009 Apr; 6(4):1135-1140. PubMed ID: 19210713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer.
    Ilic D; Hindson B; Duchesne G; Millar JL
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):81-8. PubMed ID: 23374559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM; Stock RG; Buckstein M; Stone NN
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.